Global Factors Shaping the Rapid Evolution of the Automation in Biopharma Industry Market

The automation sector within the biopharma industry is on the verge of substantial expansion, driven by advancements in technology and increasing demand for efficient manufacturing processes. As biopharmaceutical companies seek to modernize their production and research facilities, the automation market is poised for impressive growth and innovation in the coming years. Let's explore the market size projections, key players, emerging trends, and segmentation details shaping this industry.

Projected Market Growth and Size of the Automation in Biopharma Industry Market
The automation in biopharma industry market is forecasted to grow significantly, reaching a market size of $3.16 billion by 2030. This expansion is expected to occur at a compound annual growth rate (CAGR) of 7.7%. Such growth is largely fueled by greater investments in intelligent biomanufacturing infrastructure, wider acceptance of continuous manufacturing methods, and the increasing production of personalized biologics. In addition, there is a growing need for automation solutions that comply with regulatory standards, alongside a strong focus on optimizing manufacturing efficiency. Key trends anticipated to influence the market include the expanding use of robotic manufacturing platforms, deeper integration of digital twin technologies, the adoption of automated quality control systems, the broadening of end-to-end bioprocess automation, and a rising emphasis on data-driven manufacturing techniques.

Download a free sample of the automation in biopharma industry market report:
https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Corporations Driving the Automation in Biopharma Industry Market
Several influential companies currently dominate the automation in biopharma industry market. These include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton dic*kinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, and BioTek Instruments Inc.

An important development within this sector took place in January 2024, when Bruker Corporation, a US-based supplier of advanced scientific instruments and analytical solutions, acquired Chemspeed Technologies AG. Although the transaction amount was undisclosed, this acquisition is set to accelerate digital transformation in research and quality control laboratories across biopharma and life sciences. Chemspeed Technologies AG, headquartered in Switzerland, specializes in modular automation and robotics workstations designed to streamline laboratory R&D and quality assurance workflows.

The automation sector within the biopharma industry is on the verge of substantial expansion, driven by advancements in technology and increasing demand for efficient manufacturing processes. As biopharmaceutical companies seek to modernize their production and research facilities, the automation market is poised for impressive growth and innovation in the coming years. Let's explore the market size projections, key players, emerging trends, and segmentation details shaping this industry.

Projected Market Growth and Size of the Automation in Biopharma Industry Market
The automation in biopharma industry market is forecasted to grow significantly, reaching a market size of $3.16 billion by 2030. This expansion is expected to occur at a compound annual growth rate (CAGR) of 7.7%. Such growth is largely fueled by greater investments in intelligent biomanufacturing infrastructure, wider acceptance of continuous manufacturing methods, and the increasing production of personalized biologics. In addition, there is a growing need for automation solutions that comply with regulatory standards, alongside a strong focus on optimizing manufacturing efficiency. Key trends anticipated to influence the market include the expanding use of robotic manufacturing platforms, deeper integration of digital twin technologies, the adoption of automated quality control systems, the broadening of end-to-end bioprocess automation, and a rising emphasis on data-driven manufacturing techniques.

Download a free sample of the automation in biopharma industry market report:
https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Corporations Driving the Automation in Biopharma Industry Market
Several influential companies currently dominate the automation in biopharma industry market. These include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton dic*kinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, and BioTek Instruments Inc.

An important development within this sector took place in January 2024, when Bruker Corporation, a US-based supplier of advanced scientific instruments and analytical solutions, acquired Chemspeed Technologies AG. Although the transaction amount was undisclosed, this acquisition is set to accelerate digital transformation in research and quality control laboratories across biopharma and life sciences. Chemspeed Technologies AG, headquartered in Switzerland, specializes in modular automation and robotics workstations designed to streamline laboratory R&D and quality assurance workflows.

Key Factors Supporting Growth in the Automation in Biopharma Industry Market
The market's growth is supported by a wave of innovation aimed at improving biopharma manufacturing and research processes. For instance, companies are increasingly investing in smart manufacturing systems and digital solutions that boost productivity while ensuring regulatory compliance. Additionally, the shift toward personalized biologics and continuous manufacturing models is creating further demand for automation technologies that can handle complex production requirements efficiently.

Innovations and Trends Enhancing Market Demand
A notable trend is the increasing implementation of digital twin technology, which allows virtual replication of manufacturing processes for better monitoring and optimization. Similarly, robotic platforms are becoming more prevalent, offering precise and reliable automation of repetitive tasks. The integration of automated quality control systems further enhances product safety and consistency, while the move toward end-to-end bioprocess automation is streamlining operations from start to finish.

Automation in Biopharma Industry Market Segmentation Overview
This market is segmented by technology, components, and application areas to provide a detailed understanding of its structure. By technology, the market is divided into automation technology and digitization technology. Component-wise, it includes automation hardware, automation software, services related to project phases, and operational phase services. Applications are categorized into clinical phase, drug discovery phase, and production phase.

Further breaking down the technology segment, automation technology comprises process automation, laboratory automation, robotics and artificial intelligence, control systems, and programmable logic controllers (PLCs). Digitization technology covers data analytics and visualization, electronic lab notebooks (ELN), cloud computing, the Internet of Things (IoT) in pharma, and digital twin technology, each playing a crucial role in transforming biopharma manufacturing and research operations.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.